Firms
Scion Life Sciences
New York, United States
Scion Life Sciences is a New York biotechnology venture investor and company builder affiliated with Petrichor. It creates therapeutics companies around academic, industry and internally developed discoveries, combining long-term financing with scientific and operating support from initial incubation through clinical development and potential commercialization. Its internal Scion Innovations hub designs and tests protein therapeutics, antibodies and other biologics, supporting drug-discovery and company-formation work. The firm backs medicines across serious diseases rather than a neuroscience-only mandate; its team includes experienced developers of neurological and neuromuscular therapies.
- Founded
- —
- Type
- Venture capital
Funds1
Team
Operations and support
Aaron KantoffManaging Partner |
Abhishek DattaSenior Vice President & Head of Research |
Amanda Rodrigues MarianoSenior Associate Scientist, In-Vitro Pharmacology |
Andreas LoewPartner |
Anumeha RajvanshiResearch Associate-II, Molecular Biology & Protein Expression |
Ariella GolbinCo-op Student |
David KatonaHead of Business Development & Investor Relations |
Douglas SauterScientist II, Protein Sciences |
Eddie HosseinDirector of Finance |
Elliot Akama-GarrenFormer Fellow (2025/26 cohort) |
Elliot WarnerSenior Associate · Former Fellow (2023/24 cohort) |
 Hugh ChenFormer Fellow (2025/26 cohort) |
Huw NashVenture Partner |
James BellushFormer Fellow (2023/24 cohort) |
Jeffrey EdelmanPartner & Head of Operations; Chief Compliance Officer |
Kartik MenonFormer Fellow (2025/26 cohort) |
Khikmet SadykovScientist II, Antibody Discovery |
Lalo FloresVenture Partner |
Leticia AngeliniScientist II, Antibody Discovery & Protein Expression |
Mary YoungFormer Fellow (2023/24 cohort) |
MaryAnn LungarielloExecutive Assistant |
Megan BlewettPrincipal |
Miguel ChuapocoFormer Fellow (2023/24 cohort) |
Nathan BealsFormer Fellow (2024/25 cohort) |
Nick BayhiFormer Fellow (2024/25 cohort) |
Romesh SubramanianVenture Partner |
Sakshi ThakreCo-op Student |
Samuel HallManaging Partner |
Shabnam EghbaliFormer Fellow (2022/23 cohort) |
Steve O’NeilPrincipal Scientist, Protein Sciences |
Tadd WesselManaging Partner |
Todd BorlandPrincipal Scientist, in-vitro & in-vivo Pharmacology |
Wesley HuangFormer Fellow (2025/26 cohort) |
William ChourAssociate · Former Fellow (2022/23 cohort) |
William WangFormer Fellow (2022/23 cohort) |
Co-investing
No co-investors on record yet.
Investments
| $—Unknown date |  Flux Therapeutics | Scion Life Sciences |